Company Filing History:
Years Active: 2021
Title: Xudan Bi: Innovator in Pharmaceutical Chemistry
Introduction
Xudan Bi is a prominent inventor based in Yunnan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on metalloporphyrin compounds. His research focuses on the preparation and applications of these compounds, which have important implications for medical science.
Latest Patents
Xudan Bi holds a patent for a metalloporphyrin compound, which is detailed in his disclosure titled "Metalloporphyrin compounds, preparation and uses thereof." This patent relates to the specific recognition of HIV RNA and the effective inhibition of HIV reverse transcriptase. The compound can be represented by a specific formula, and it includes optical isomers, pharmaceutically-acceptable salts, or solvates. The applications of this compound extend to the preparation of reagents for selectively recognizing HIV TAR RNA and serving as a HIV reverse transcriptase inhibitor. He has 1 patent to his name.
Career Highlights
Xudan Bi is affiliated with Yunnan University, where he conducts his research and development activities. His work has garnered attention for its potential to contribute to the fight against HIV, showcasing his commitment to advancing pharmaceutical chemistry.
Collaborations
Xudan Bi collaborates with notable colleagues, including Feng Gao and Yuechen Zhou. Their combined expertise enhances the research efforts at Yunnan University, fostering an environment of innovation and discovery.
Conclusion
Xudan Bi's contributions to pharmaceutical chemistry, particularly through his patent on metalloporphyrin compounds, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for significant medical applications.